Timpani Capital Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Timpani Capital Management’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-10,227	Closed	-$1.19M	–	117
2016 Q3	$1.19M	Buy	10,227 +2,211	+28%	+$216K	0.47%	70
2016 Q2	$635K	Buy	8,016 +2,502	+45%	+$217K	0.27%	94
2016 Q1	$419K	Sell	5,514 -6,442	-54%	-$410K	0.18%	91
2015 Q4	$1.07M	Sell	11,956 -4,884	-29%	-$469K	0.43%	80
2015 Q3	$1.89M	Sell	16,840 -6,467	-28%	-$744K	0.76%	62
2015 Q2	$2.37M	Buy	23,307 +1,852	+9%	+$192K	0.69%	63
2015 Q1	$2.34M	Buy	21,455 +2,787	+15%	+$285K	0.7%	60
2014 Q4	$1.7M	Buy	18,668 +827	+5%	+$70.5K	0.67%	67
2014 Q3	$1.42M	Buy	17,841 +873	+5%	+$66.7K	0.65%	60
2014 Q2	$1.32M	Sell	16,968 -1,782	-10%	-$139K	0.59%	63
2014 Q1	$1.51M	Buy	+18,750	New	+$1.72M	0.8%	48

Other funds holding PLXP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Middleton & Co Boston, Massachusetts $877M AUM 15.2% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Timpani Capital Management's PLXP Position: Q4 2016 in Review

Timpani Capital Management sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2016, closing a stake of 10,227 shares — an estimated $1.19M sold.

Timpani Capital Management first reported a position in PLXP in Q1 2014 and held it in 11 quarters. The position peaked at $2.37M in Q2 2015. 19 funds tracked by Wall St. Rank hold PLXP as of Q4 2016.

Timpani Capital Management reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Timpani Capital Management sold 10,227 PLx Pharma Inc. Common Stock shares in Q4 2016, an estimated $1.19M.
Timpani Capital Management first reported a position in PLx Pharma Inc. Common Stock in Q1 2014 and held it in 11 quarters.
Timpani Capital Management's PLx Pharma Inc. Common Stock position peaked at $2.37M in Q2 2015.
19 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2016.

Based on Timpani Capital Management's 13F filing for Q4 2016, filed 9 Feb 2017.